[Coronary artery disease multivessel not amenable to revascularization: contemporary cohort].

Gustavo Inzunza-Cervantes, Juan Ramón Herrera-Gavilanes, Josué Abisai Félix-Córdova, Luis Alejandro Padilla-Islas, José Manuel Ornelas-Aguirre, Víctor Adrián Cortés-García
{"title":"[Coronary artery disease multivessel not amenable to revascularization: contemporary cohort].","authors":"Gustavo Inzunza-Cervantes, Juan Ramón Herrera-Gavilanes, Josué Abisai Félix-Córdova, Luis Alejandro Padilla-Islas, José Manuel Ornelas-Aguirre, Víctor Adrián Cortés-García","doi":"10.5281/zenodo.11397136","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Severe diffuse coronary artery disease with anatomy that is not amenable to revascularization represents a poorly studied entity, with a poorly defined prognosis and prevalence, associated with high morbidity and mortality, poor quality of life and high hospitalization rates.</p><p><strong>Objective: </strong>Due to the limited evidence in this clinical field and the absence of contemporary studies, we decided to explore this line of research, determining epidemiological, clinical and prognostic aspects.</p><p><strong>Material and methods: </strong>Analytical, retrospective observational cohort study, carried out in a National Medical Center.</p><p><strong>Results: </strong>The prevalence of three-vessel coronary artery disease not susceptible to revascularization was 12.2%, the majority were men (66%), over 65 years of age, with a high burden of comorbidities: pharmacological management consisted of beta blockers (91.5 %), antiplatelet aggregation (95.3%) and statins (95.3%): cardiovascular mortality was 9.4%, with myocardial infarction occurring in 10.4%: the predictor variables of mortality were chronic kidney disease, age over 70 years, insufficiency mitral valve.</p><p><strong>Conclusion: </strong>Coronary artery disease of three vessels not susceptible to revascularization continues to be a frequent entity, with a high-risk clinical and anatomical profile, with a better contemporary prognosis despite the multiple gaps in knowledge that limit its understanding and treatment.</p>","PeriodicalId":94200,"journal":{"name":"Revista medica del Instituto Mexicano del Seguro Social","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista medica del Instituto Mexicano del Seguro Social","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5281/zenodo.11397136","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Severe diffuse coronary artery disease with anatomy that is not amenable to revascularization represents a poorly studied entity, with a poorly defined prognosis and prevalence, associated with high morbidity and mortality, poor quality of life and high hospitalization rates.

Objective: Due to the limited evidence in this clinical field and the absence of contemporary studies, we decided to explore this line of research, determining epidemiological, clinical and prognostic aspects.

Material and methods: Analytical, retrospective observational cohort study, carried out in a National Medical Center.

Results: The prevalence of three-vessel coronary artery disease not susceptible to revascularization was 12.2%, the majority were men (66%), over 65 years of age, with a high burden of comorbidities: pharmacological management consisted of beta blockers (91.5 %), antiplatelet aggregation (95.3%) and statins (95.3%): cardiovascular mortality was 9.4%, with myocardial infarction occurring in 10.4%: the predictor variables of mortality were chronic kidney disease, age over 70 years, insufficiency mitral valve.

Conclusion: Coronary artery disease of three vessels not susceptible to revascularization continues to be a frequent entity, with a high-risk clinical and anatomical profile, with a better contemporary prognosis despite the multiple gaps in knowledge that limit its understanding and treatment.

[不适于血管再通的多血管冠状动脉疾病:当代队列]。
背景:严重弥漫性冠状动脉疾病的解剖结构不适于血管再通,是一种研究较少的疾病,其预后和发病率不明确,与高发病率和死亡率、低生活质量和高住院率有关:由于这一临床领域的证据有限且缺乏当代研究,我们决定探索这一研究方向,确定流行病学、临床和预后方面的问题:在一家国家医疗中心开展的分析性、回顾性队列观察研究:结果:三血管冠状动脉疾病的发病率为 12.2%,大多数为男性(66%),年龄在 65 岁以上,合并症较多:药物治疗包括β受体阻滞剂(91.5 %)、抗血小板聚集(95.3%)和他汀类药物(95.3%):心血管死亡率为 9.4%,其中心肌梗死发生率为 10.4%:死亡率的预测变量为慢性肾病、70 岁以上、二尖瓣关闭不全:结论:三支血管的冠状动脉疾病不容易进行血管再通,仍然是一种常见病,具有高风险的临床和解剖特征,尽管在知识方面存在多种空白,限制了对其的理解和治疗,但其当代预后较好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信